Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Emerging Insights and Global Trends in the Relationship between Selenium and Thyroid Diseases: A Bibliometric Analysis

Author(s): Yuqing Wu, Tiantian Cai, Yuan Tao, Jing Zhao and Jinan Zhang*

Volume 24, Issue 7, 2024

Published on: 18 September, 2023

Page: [808 - 819] Pages: 12

DOI: 10.2174/1871530323666230918121353

Price: $65

Abstract

Objective: Selenium, a significant trace element needed by the human body, is closely related to thyroid. Therefore, this study aimed to explore the status of selenium and thyroid diseases, analyze emerging insights, and predict future trends.

Methods: Literature on selenium and thyroid included in the core database of Web of Science from January 1992 to October 2022 was retrieved. CiteSpace and VOSviewer software were used for visual analysis in terms of publication, author, country, institution, co-citation, and keywords.

Results: A total of 1,142 works of literature were included after the screening, and the annual publication showed a fluctuating upward trend. The country and the institution with the highest publication volume were the United States and Charité Universitätsmedizin Berlin, respectively. In terms of authors, Schomburg L has formed a cooperative network and has published the largest number of papers and made great contributions in this field. The biggest cluster of keywords was trace elements, and the hot keywords in recent years were oxidative stress, Hashimoto's thyroiditis, cadmium, copper, etc.

Conclusion: This paper analyzes the current status, insights, and trends of the studies on selenium and thyroid diseases by the method of bibliometrics and delivers ideas and methods for subsequent research in this field. The therapeutic effect of selenium on Hashimoto's thyroiditis is controversial and needs further research, and oxidative stress is also a research hotspot in this field. The crossstudy of multiple trace elements and diseases may be the development trend in the future.

Keywords: Bibliometric analysis, selenium, thyroid disease, insight, trend, VOSviewer, CiteSpace.

« Previous Next »
[1]
Vanderpump, M.P.J. The epidemiology of thyroid disease. Br. Med. Bull., 2011, 99(1), 39-51.
[http://dx.doi.org/10.1093/bmb/ldr030] [PMID: 21893493]
[2]
Liu, Y.; Huang, H.; Zeng, J.; Sun, C. Thyroid volume, goiter prevalence, and selenium levels in an iodine-sufficient area: A cross-sectional study. BMC Public Health, 2013, 13(1), 1153.
[http://dx.doi.org/10.1186/1471-2458-13-1153] [PMID: 24321191]
[3]
Zimmermann, M.B.; Boelaert, K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol., 2015, 3(4), 286-295.
[http://dx.doi.org/10.1016/S2213-8587(14)70225-6] [PMID: 25591468]
[4]
Vanderpump, M.P. Epidemiology of iodine deficiency. Minerva Med., 2017, 108(2), 116-123.
[http://dx.doi.org/10.23736/S0026-4806.16.04918-1] [PMID: 27973468]
[5]
Winther, K.H.; Rayman, M.P.; Bonnema, S.J.; Hegedüs, L. Selenium in thyroid disorders: Essential knowledge for clinicians. Nat. Rev. Endocrinol., 2020, 16(3), 165-176.
[http://dx.doi.org/10.1038/s41574-019-0311-6] [PMID: 32001830]
[6]
Schomburg, L.; Köhrle, J. On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol. Nutr. Food Res., 2008, 52(11), 1235-1246.
[http://dx.doi.org/10.1002/mnfr.200700465] [PMID: 18686295]
[7]
Köhrle, J. Selenium and the thyroid. Curr. Opin. Endocrinol. Diabetes Obes., 2013, 20(5), 441-448.
[http://dx.doi.org/10.1097/01.med.0000433066.24541.88] [PMID: 23974773]
[8]
Rayman, M.P. Selenium and human health. Lancet, 2012, 379(9822), 1256-1268.
[http://dx.doi.org/10.1016/S0140-6736(11)61452-9] [PMID: 22381456]
[9]
van Eck, N.J.; Waltman, L. Citation-based clustering of publications using citnetexplorer and vosviewer. Scientometrics, 2017, 111(2), 1053-1070.
[http://dx.doi.org/10.1007/s11192-017-2300-7] [PMID: 28490825]
[10]
Rayman, M.P. Food-chain selenium and human health: Emphasis on intake. Br. J. Nutr., 2008, 100(2), 254-268.
[http://dx.doi.org/10.1017/S0007114508939830] [PMID: 18346308]
[11]
Sun, Q.; Mehl, S.; Renko, K.; Seemann, P.; Görlich, C.L.; Hackler, J.; Minich, W.B.; Kahaly, G.J.; Schomburg, L. Natural autoimmunity to selenoprotein p impairs selenium transport in hashimoto’s thyroiditis. Int. J. Mol. Sci., 2021, 22(23), 13088.
[http://dx.doi.org/10.3390/ijms222313088] [PMID: 34884891]
[12]
Mehl, S.; Sun, Q.; Görlich, C.L.; Hackler, J.; Kopp, J.F.; Renko, K.; Mittag, J.; Schwerdtle, T.; Schomburg, L. Cross-sectional analysis of trace element status in thyroid disease. J. Trace Elem. Med. Biol., 2020, 58, 126430.
[http://dx.doi.org/10.1016/j.jtemb.2019.126430] [PMID: 31835129]
[13]
Mazokopakis, E.E.; Chatzipavlidou, V. Hashimoto’s thyroiditis and the role of selenium. Current concepts. Hell. J. Nucl. Med., 2007, 10(1), 6-8.
[PMID: 17450242]
[14]
Ralli, M.; Angeletti, D.; Fiore, M.; D’Aguanno, V.; Lambiase, A.; Artico, M.; de Vincentiis, M.; Greco, A. Hashimoto’s thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun. Rev., 2020, 19(10), 102649.
[http://dx.doi.org/10.1016/j.autrev.2020.102649] [PMID: 32805423]
[15]
Klubo-Gwiezdzinska, J.; Wartofsky, L. Hashimoto thyroiditis: An evidence-based guide: etiology, diagnosis and treatment. Polish Arch. Inter Med, 2022, 132(3), 10.
[http://dx.doi.org/10.20452/pamw.16222] [PMID: 35243857]
[16]
Nourbakhsh, M.; Ahmadpour, F.; Chahardoli, B.; Malekpour-Dehkordi, Z.; Nourbakhsh, M.; Hosseini-Fard, S.R.; Doustimotlagh, A.; Golestani, A.; Razzaghy-Azar, M. Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto’s thyroiditis and hypothyroidism. J. Trace Elem. Med. Biol., 2016, 34, 10-14.
[http://dx.doi.org/10.1016/j.jtemb.2015.10.003] [PMID: 26854239]
[17]
Valea, A.; Georgescu, C.E. Selenoproteins in human body: Focus on thyroid pathophysiology. Hormones, 2018, 17(2), 183-196.
[http://dx.doi.org/10.1007/s42000-018-0033-5] [PMID: 29873029]
[18]
Zagrodzki, P.; Kryczyk, J. The importance of selenium in Hashimoto’s disease. Postepy Hig. Med. Dosw., 2014, 68, 1129-1137.
[http://dx.doi.org/10.5604/17322693.1120989] [PMID: 25228521]
[19]
Wu, Q.; Wang, Y.; Chen, P.; Wei, J.; Lv, H.; Wang, S.; Wu, Y.; Zhao, X.; Peng, X.; Rijntjes, E.; Wang, Y.; Schomburg, L.; Shi, B. Increased incidence of hashimoto thyroiditis in selenium deficiency: A prospective 6-year cohort study. J. Clin. Endocrinol. Metab., 2022, 107(9), e3603-e3611.
[http://dx.doi.org/10.1210/clinem/dgac410] [PMID: 35789269]
[20]
Santos, L.; Neves, C.; Melo, M.; Soares, P. Selenium and selenoproteins in immune mediated thyroid disorders. Diagnostics, 2018, 8(4), 70.
[http://dx.doi.org/10.3390/diagnostics8040070] [PMID: 30287753]
[21]
Nacamulli, D.; Petricca, D.; Mian, C. Selenium and autoimmune thyroiditis. J. Endocrinol. Invest., 2013, 36(10), 8-14.
[PMID: 24419054]
[22]
Winther, K.H.; Watt, T.; Bjørner, J.B.; Cramon, P.; Feldt-Rasmussen, U.; Gluud, C.; Gram, J.; Groenvold, M.; Hegedüs, L.; Knudsen, N.; Rasmussen, Å.K.; Bonnema, S.J. The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): Study protocol for a randomized controlled trial. Trials, 2014, 15(1), 115.
[http://dx.doi.org/10.1186/1745-6215-15-115] [PMID: 24716668]
[23]
Pirola, I.; Gandossi, E.; Agosti, B.; Delbarba, A.; Cappelli, C. Selenium supplementation could restore euthyroidism in subclinical hypothyroid patients with autoimmune thyroiditis. Endokrynol. Pol., 2016, 67(6), 567-571.
[http://dx.doi.org/10.5603/EP.2016.0064] [PMID: 28042649]
[24]
Wichman, J.; Winther, K.H.; Bonnema, S.J.; Hegedüs, L. Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: A systematic review and meta-analysis. Thyroid, 2016, 26(12), 1681-1692.
[http://dx.doi.org/10.1089/thy.2016.0256] [PMID: 27702392]
[25]
Kryczyk-Kozioł J.; Zagrodzki, P.; Prochownik, E.; Błażewska-Gruszczyk, A.; Słowiaczek, M.; Sun, Q.; Schomburg, L.; Ochab, E.; Bartyzel, M. Positive effects of selenium supplementation in women with newly diagnosed Hashimoto’s thyroiditis in an area with low selenium status. Int. J. Clin. Pract., 2021, 75(9), e14484.
[http://dx.doi.org/10.1111/ijcp.14484] [PMID: 34107151]
[26]
Wang, L.F.; Sun, R.X.; Li, C.F.; Wang, X.H. The effects of selenium supplementation on antibody titres in patients with Hashimoto’s thyroiditis. Endokrynol. Pol., 2021, 72(6), 666-667.
[http://dx.doi.org/10.5603/EP.a2021.0074] [PMID: 34378788]
[27]
Hawkes, W.C.; Richter, B.D.; Alkan, Z.; Souza, E.C.; Derricote, M.; Mackey, B.E.; Bonnel, E.L. Response of selenium status indicators to supplementation of healthy North American men with high-selenium yeast. Biol. Trace Elem. Res., 2008, 122(2), 107-121.
[http://dx.doi.org/10.1007/s12011-007-8066-7] [PMID: 18193397]
[28]
Esposito, D.; Rotondi, M.; Accardo, G.; Vallone, G.; Conzo, G.; Docimo, G.; Selvaggi, F.; Cappelli, C.; Chiovato, L.; Giugliano, D.; Pasquali, D. Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: Clinical results of a blinded placebo-controlled randomized prospective trial. J. Endocrinol. Invest., 2017, 40(1), 83-89.
[http://dx.doi.org/10.1007/s40618-016-0535-4] [PMID: 27572248]
[29]
Pekar, J.; Pekar, J.; Skolarczyk, J.; Skórzyńska-Dziduszko, K.; Małecka-Massalska, T. Effect of selenium supplementation in thyroid gland diseases. J. Elem., 2016, 22(1/2017), 91-103.
[http://dx.doi.org/10.5601/jelem.2015.20.4.1030]
[30]
Winther, K.H.; Wichman, J.E.M.; Bonnema, S.J.; Hegedüs, L. Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis. Endocrine, 2017, 55(2), 376-385.
[http://dx.doi.org/10.1007/s12020-016-1098-z] [PMID: 27683225]
[31]
Pirola, I.; Rotondi, M.; Cristiano, A.; Maffezzoni, F.; Pasquali, D.; Marini, F.; Coperchini, F.; Paganelli, M.; Apostoli, P.; Chiovato, L.; Ferlin, A.; Cappelli, C. Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study. Endocrinología, Diabetes y Nutrición, 2020, 67(1), 28-35.
[http://dx.doi.org/10.1016/j.endien.2019.12.002] [PMID: 31196739]
[32]
Filipowicz, D.; Majewska, K.; Kalantarova, A.; Szczepanek-Parulska, E. Ruchała, M. The rationale for selenium supplementation in patients with autoimmune thyroiditis, according to the current state of knowledge. Endokrynol. Pol., 2021, 72(2), 153-162.
[http://dx.doi.org/10.5603/EP.a2021.0017] [PMID: 33970480]
[33]
Winther, K.H.; Bonnema, S.J.; Hegedüs, L. Is selenium supplementation in autoimmune thyroid diseases justified? Curr. Opin. Endocrinol. Diabetes Obes., 2017, 24(5), 348-355.
[http://dx.doi.org/10.1097/MED.0000000000000356] [PMID: 28639965]
[34]
Wojciechowska-Durczynska, K.; Lewinski, A. Search for relevant indications for selenium supplementation in thyroid diseases. Neuroendocrinol. Lett., 2017, 38(4), 237-241.
[PMID: 28871707]
[35]
Winther, K.H.; Papini, E.; Attanasio, R.; Negro, R.; Hegedüs, L.A. 2018 european thyroid association survey on the use of selenium supplementation in hashimoto’s thyroiditis. Eur. Thyroid J., 2020, 9(2), 99-105.
[http://dx.doi.org/10.1159/000504781] [PMID: 32257959]
[36]
Qiu, Y.; Xing, Z.; Xiang, Q.; Yang, Q.; Zhu, J.; Su, A. Insufficient evidence to support the clinical efficacy of selenium supplementation for patients with chronic autoimmune thyroiditis. Endocrine, 2021, 73(2), 384-397.
[http://dx.doi.org/10.1007/s12020-021-02642-z] [PMID: 33774780]
[37]
Sadani, G.R.; Nadkarni, G.D. Role of reactive oxygen species in induced hypothyroid goitres and hyperthyroidism in rats. Med. Sci. Res., 1996, 24(12), 835-836.
[38]
Gheorghiu, M.L.; Badiu, C. Selenium involvement in mitochondrial function in thyroid disorders. Hormones , 2020, 19(1), 25-30.
[http://dx.doi.org/10.1007/s42000-020-00173-2] [PMID: 31960358]
[39]
Marinò, M.; Dottore, G.; Leo, M.; Marcocci, C. Mechanistic pathways of selenium in the treatment of Graves’ disease and Graves’ orbitopathy. Horm. Metab. Res., 2018, 50(12), 887-893.
[http://dx.doi.org/10.1055/a-0658-7889] [PMID: 30096720]
[40]
Kryczyk, J.; Zagrodzki, P. Selenium in Graves’ disease. Postepy Hig. Med. Dosw., 2013, 67, 491-498.
[http://dx.doi.org/10.5604/17322693.1051000] [PMID: 23752601]
[41]
Ruggeri, R.M.; Campennì, A.; Giuffrida, G.; Casciaro, M.; Barbalace, M.C.; Hrelia, S.; Trimarchi, F.; Cannavò, S.; Gangemi, S. Oxidative stress as a key feature of autoimmune thyroiditis: An update. Minerva Endocrinol., 2021, 45(4), 326-344.
[http://dx.doi.org/10.23736/S0391-1977.20.03268-X] [PMID: 32969631]
[42]
Dağdeviren, M.; Or Koca, A.; Akkan, T.; Neşelioğlu, S.; Erel, Ö.; Altay, M. Is oxidative stress a factor in the pathogenesis of subacute thyroiditis? Endokrynol. Pol., 2022, 73(1), 64-70.
[http://dx.doi.org/10.5603/EP.a2021.0105] [PMID: 35156704]
[43]
Guo, H.; Yang, X.; Xu, J.; Hou, X.; Sun, X. Effect of selenium on thyroid hormone metabolism in filial cerebrum of mice with excessive iodine exposure. Biol. Trace Elem. Res., 2006, 113(3), 281-296.
[http://dx.doi.org/10.1385/BTER:113:3:281] [PMID: 17194928]
[44]
Samir, M.; Awady, M.Y. Serum selenium levels in multinodular goitre. Clin. Otolaryngol. Allied Sci., 1998, 23(6), 512-514.
[http://dx.doi.org/10.1046/j.1365-2273.1998.2360512.x] [PMID: 9884803]
[45]
Kucharzewski, M.; Braziewicz, J.; Majewska, U.; Gózdz, S. Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biol. Trace Elem. Res., 2002, 88(1), 25-30.
[http://dx.doi.org/10.1385/BTER:88:1:25] [PMID: 12117262]
[46]
Kandhro, G.A.; Kazi, T.G. Sirajuddin; Kolachi, N.F.; Kazi, N.; Afridi, H.I.; Baig, J.A.; Shah, A.Q.; Wadhwa, S.K.; Khan, S.; Arain, M.B. Effects of selenium supplementation on iodine and thyroid hormone status in a selected population with goitre in Pakistan. Clin. Lab., 2011, 57(7-8), 575-585.
[PMID: 21888022]
[47]
Zhou, Q.; Xue, S.; Zhang, L.; Chen, G. Trace elements and the thyroid. Front. Endocrinol., 2022, 13, 904889.
[http://dx.doi.org/10.3389/fendo.2022.904889] [PMID: 36353227]
[48]
Wu, Q.; Rayman, M.P.; Lv, H.; Schomburg, L.; Cui, B.; Gao, C.; Chen, P.; Zhuang, G.; Zhang, Z.; Peng, X.; Li, H.; Zhao, Y.; He, X.; Zeng, G.; Qin, F.; Hou, P.; Shi, B. Low population selenium status is associated with increased prevalence of thyroid disease. J. Clin. Endocrinol. Metab., 2015, 100(11), 4037-4047.
[http://dx.doi.org/10.1210/jc.2015-2222] [PMID: 26305620]
[49]
Rayman, M.P. Selenium intake, status, and health: A complex relationship. Hormones, 2020, 19(1), 9-14.
[http://dx.doi.org/10.1007/s42000-019-00125-5] [PMID: 31388899]
[50]
Nettore, I.C.; De Nisco, E.; Desiderio, S.; Passaro, C.; Maione, L.; Negri, M.; Albano, L.; Pivonello, R.; Pivonello, C.; Portella, G.; Ungaro, P.; Colao, A.; Macchia, P.E. Selenium supplementation modulates apoptotic processes in thyroid follicular cells. Biofactors, 2017, 43(3), 415-423.
[http://dx.doi.org/10.1002/biof.1351] [PMID: 28251705]
[51]
Constantinescu-Aruxandei, D.; Frincu, R.M.; Capra, L.; Oancea, F. Selenium analysis and speciation in dietary supplements based on next-generation selenium ingredients. Nutrients, 2018, 10(10), 1466.
[http://dx.doi.org/10.3390/nu10101466]
[52]
Ferro, C.; Florindo, H.F.; Santos, H.A. Selenium nanoparticles for biomedical applications: From development and characterization to therapeutics. Adv. Healthc. Mater., 2021, 10(16), 2100598.
[http://dx.doi.org/10.1002/adhm.202100598] [PMID: 34121366]
[53]
Baltaci, A.K.; Mogulkoc, R.; Belviranli, M. Serum levels of calcium, selenium, magnesium, phosphorus, chromium, copper and iron--their relation to zinc in rats with induced hypothyroidism. Acta Clin. Croat., 2013, 52(2), 151-156.
[PMID: 24053074]
[54]
Rasic-Milutinovic, Z.; Jovanovic, D.; Bogdanovic, G.; Trifunovic, J.; Mutic, J. Potential influence of selenium, copper, zinc and cadmium on L-thyroxine substitution in patients with Hashimoto thyroiditis and hypothyroidism. Exp. Clin. Endocrinol. Diabetes, 2016, 125(2), 79-85.
[http://dx.doi.org/10.1055/s-0042-116070] [PMID: 27793066]
[55]
Kim, M.J.; Kim, S.C.; Chung, S.; Kim, S.; Yoon, J.W.; Park, Y.J. Exploring the role of copper and selenium in the maintenance of normal thyroid function among healthy Koreans. J. Trace Elem. Med. Biol., 2020, 61, 126558.
[http://dx.doi.org/10.1016/j.jtemb.2020.126558] [PMID: 32480050]
[56]
Talebi, S.; Ghaedi, E.; Sadeghi, E.; Mohammadi, H.; Hadi, A.; Clark, C.C.T.; Askari, G. Trace element status and hypothyroidism: A systematic review and meta-analysis. Biol. Trace Elem. Res., 2020, 197(1), 1-14.
[http://dx.doi.org/10.1007/s12011-019-01963-5] [PMID: 31820354]
[57]
Hu, M.J.; He, J.L.; Tong, X.R.; Yang, W.J.; Zhao, H.H.; Li, G.A.; Huang, F. Associations between essential microelements exposure and the aggressive clinicopathologic characteristics of papillary thyroid cancer. Biometals, 2021, 34(4), 909-921.
[http://dx.doi.org/10.1007/s10534-021-00317-w] [PMID: 33961183]
[58]
Xu, J.; Liu, X.L.; Yang, X.F.; Guo, H.L.; Zhao, L.; Sun, X.F. Supplemental selenium alleviates the toxic effects of excessive iodine on thyroid. Biol. Trace Elem. Res., 2011, 141(1-3), 110-118.
[http://dx.doi.org/10.1007/s12011-010-8728-8] [PMID: 20517655]
[59]
Gustin, K.; Vahter, M.; Barman, M.; Jacobsson, B.; Skröder, H.; Filipsson Nyström, H.; Sandin, A.; Sandberg, A.S.; Wold, A.E.; Kippler, M. Assessment of joint impact of iodine, selenium, and zinc status on women’s third-trimester plasma thyroid hormone concentrations. J. Nutr., 2022, 152(7), 1737-1746.
[http://dx.doi.org/10.1093/jn/nxac081] [PMID: 35383840]
[60]
Son, H.; Lee, S.M.; Yoon, R.G.; Lee, H.; Lee, I.; Kim, S.; Chung, W.Y.; Lee, J.W. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer. Hell. J. Nucl. Med., 2017, 20(1), 62-70.
[http://dx.doi.org/10.1967/s002449910508] [PMID: 28315910]

Rights & Permissions Print Cite
Article Metrics
97
2
© 2024 Bentham Science Publishers | Privacy Policy